Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for gastroenteroscopy sedation in suspected sleep apnea
ChiCTR2300074758Phase 4Recruiting
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by The First Hospital of Fujian Medical University. Primary endpoint: Hypoxemia. Started Apr 2023; status: recruiting.
02
Drugs
remimazolam
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ChiCTR2300074758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074758.